| Dr Lesley Marie Weghorn, MD | |
|
830 Thomas More Pkwy, Suite 200 A, Edgewood, KY 41017-5102 | |
| (859) 341-3383 | |
| (859) 578-2013 |
| Full Name | Dr Lesley Marie Weghorn |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 830 Thomas More Pkwy, Edgewood, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821050717 | NPI | - | NPPES |
| 259640 | Medicaid | OH | |
| 64103013 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 39485 (Kentucky) | Primary |
| Entity Name | Summit Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026169 PECOS PAC ID: 2163326240 Enrollment ID: O20031120000738 |
News Archive
A new preprint research paper posted to the medRxiv* server addresses the need to assess this risk by examining whether SARS-CoV-2 transmission can interact with vaccination rates to select vaccine-resistant strains. The study aims to provide data to shape effective countermeasures against the threat of viral resistance.
Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMP® 200 Reader in the US.
Results from a large, prospective clinical trial add to mounting evidence that adolescent and young adult patients-aged 16 to 39 with acute lymphoblastic leukemia (ALL)-tend to fare better when treated with high-intensity pediatric protocols than previous patients who were treated with standard adult regimens.
Tests of cells collected from the umbilical cord blood vessel walls at birth can predict death or poor pulmonary outcomes in extremely preterm infants, say researchers at the University of Alabama at Birmingham.
Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a Massachusetts General Hospital (MGH) physician. In the December issue of Obstetrics & Gynecology, Erin Tracy, MD, MPH, warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lesley Marie Weghorn, MD Po Box 635283, Cincinnati, OH 45263-5283 Ph: (859) 341-3383 | Dr Lesley Marie Weghorn, MD 830 Thomas More Pkwy, Suite 200 A, Edgewood, KY 41017-5102 Ph: (859) 341-3383 |
News Archive
A new preprint research paper posted to the medRxiv* server addresses the need to assess this risk by examining whether SARS-CoV-2 transmission can interact with vaccination rates to select vaccine-resistant strains. The study aims to provide data to shape effective countermeasures against the threat of viral resistance.
Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMP® 200 Reader in the US.
Results from a large, prospective clinical trial add to mounting evidence that adolescent and young adult patients-aged 16 to 39 with acute lymphoblastic leukemia (ALL)-tend to fare better when treated with high-intensity pediatric protocols than previous patients who were treated with standard adult regimens.
Tests of cells collected from the umbilical cord blood vessel walls at birth can predict death or poor pulmonary outcomes in extremely preterm infants, say researchers at the University of Alabama at Birmingham.
Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a Massachusetts General Hospital (MGH) physician. In the December issue of Obstetrics & Gynecology, Erin Tracy, MD, MPH, warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.
› Verified 7 days ago
Dr. Lisa Williams Miller, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 108 Beech Dr., Edgewood, KY 41017 Phone: 859-331-8655 Fax: 859-341-7198 | |
Dr. Griffith Ernest Quinby Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 233 Colony Dr., Edgewood, KY 41017 Phone: 859-655-5642 | |
Dr. Radhika Bala Ramesh, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 20 Medical Village Dr, Ste 102, Edgewood, KY 41017 Phone: 859-341-1011 Fax: 859-341-7198 | |
Dr. Meredith A Landorf, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 830 Thomas More Pkwy, Edgewood, KY 41017 Phone: 859-301-8686 | |
Dr. Kevin Joseph Kelly, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 20 Medical Village Dr, Suite 102, Edgewood, KY 41017 Phone: 859-341-1011 Fax: 859-341-7198 | |
Jeffrey A Whitsett, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-2423 Fax: 859-301-2066 | |
Mrs. Jamie D Mudd, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 20 Medical Village Dr., Suite 102, Edgewood, KY 41017 Phone: 859-341-1011 Fax: 859-341-7198 |